Stock Market News

Regeneron Pharma (REGN) News

10 hours Regeneron Pharmaceuticals, Inc. (REGN): Among the Most Promising Cancer Stocks According to Hedge FundsInsider Monkey X

4 days Regeneron Pharmaceuticals, Inc. (REGN) Jefferies London Healthcare Conference (Transcript)Seeking Alpha X

4 days Here’s Why Regeneron Pharmaceuticals (REGN) Declined in Q3Insider Monkey X

5 days FDA Accepts SNY and REGN’s Dupixent Re-Submitted sBLA for UrticariaZacks X

1 week 2 Top Growth Stocks to Buy on the DipThe Motley Fool X

3 weeks Regeneron Pharma earnings beat by $0.74, revenue topped estimatesInvesting.com X

4 weeks Regeneron to Report Q3 Earnings: What’s in the Offing?Zacks X

4 weeks Brighton Jones LLC Decreases Stake in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)MarketBeat X

4 weeks Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Shares Acquired by Silver Oak Securities IncorporatedMarketBeat X

1 month Regeneron Pharmaceuticals (NASDAQ:REGN) Receives “Neutral” Rating from Cantor FitzgeraldMarketBeat X

1 month Regeneron Pharmaceuticals (NASDAQ:REGN) Price Target Lowered to $1,080.00 at BarclaysMarketBeat X

1 month Regeneron Pharmaceuticals (NASDAQ:REGN) Price Target Cut to $1,050.00 by Analysts at Wells Fargo & CompanyMarketBeat X

1 month Regeneron Pharmaceuticals (NASDAQ:REGN) Earns “Outperform” Rating from Royal Bank of CanadaMarketBeat X

1 month Creative Planning Purchases 2,178 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)MarketBeat X

1 month Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Holdings Boosted by Raymond James & AssociatesMarketBeat X